Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo.

Goldberg SC, Schulz SC, Schulz PM, Resnick RJ, Hamer RM, Friedel RO.

Arch Gen Psychiatry. 1986 Jul;43(7):680-6.

PMID:
3521531
2.

Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo.

Soloff PH, George A, Nathan RS, Schulz PM, Ulrich RF, Perel JM.

Arch Gen Psychiatry. 1986 Jul;43(7):691-7.

PMID:
3521532
3.

Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol.

Serban G, Siegel S.

Am J Psychiatry. 1984 Nov;141(11):1455-8.

PMID:
6388363
4.

Pharmacotherapy for patients with borderline personality disorder.

Gunderson JG.

Arch Gen Psychiatry. 1986 Jul;43(7):698-700. No abstract available.

PMID:
2872871
5.

Risperidone in the treatment of schizotypal personality disorder.

Koenigsberg HW, Reynolds D, Goodman M, New AS, Mitropoulou V, Trestman RL, Silverman J, Siever LJ.

J Clin Psychiatry. 2003 Jun;64(6):628-34.

PMID:
12823075
6.

An open, noncomparative study of amoxapine in borderline disorders.

Jensen HV, Andersen J.

Acta Psychiatr Scand. 1989 Jan;79(1):89-93.

PMID:
2648768
7.

Effect of tranquilizers on borderline and schizotypal patients questioned.

Rockland LH.

Am J Psychiatry. 1985 May;142(5):665-6. No abstract available.

PMID:
3885764
8.

Efficacy of phenelzine and haloperidol in borderline personality disorder.

Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF.

Arch Gen Psychiatry. 1993 May;50(5):377-85.

PMID:
8489326
9.

Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response.

Soloff PH, George A, Nathan S, Schulz PM, Cornelius JR, Herring J, Perel JM.

J Clin Psychopharmacol. 1989 Aug;9(4):238-46.

PMID:
2768542
10.

The use of low-dose neuroleptics in the treatment of "schizo-obsessive" patients.

Schulz SC.

Am J Psychiatry. 1986 Oct;143(10):1318-9. No abstract available.

PMID:
2876650
11.

Borderline personality disorder: symptomatology and MMPI characteristics.

Resnick RJ, Schulz P, Schulz SC, Hamer RM, Friedel RO, Goldberg SC.

J Clin Psychiatry. 1983 Aug;44(8):289-92.

PMID:
6874649
12.

Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.

Bellino S, Paradiso E, Bogetto F.

J Clin Psychiatry. 2006 Jul;67(7):1042-6.

PMID:
16889446
13.

Auditory P300 does not differentiate borderline personality disorder from schizotypal personality disorder.

Kutcher SP, Blackwood DH, Gaskell DF, Muir WJ, St Clair DM.

Biol Psychiatry. 1989 Dec;26(8):766-74.

PMID:
2590690
14.

A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.

Hollander E, Allen A, Lopez RP, Bienstock CA, Grossman R, Siever LJ, Merkatz L, Stein DJ.

J Clin Psychiatry. 2001 Mar;62(3):199-203.

PMID:
11305707
15.

The Borderline Syndrome Index. Clinical validity and utility.

Edell WS.

J Nerv Ment Dis. 1984 May;172(5):254-63.

PMID:
6716090
16.

Internal consistency, intercriterion overlap and diagnostic efficiency of criteria sets for DSM-IV schizotypal, borderline, avoidant and obsessive-compulsive personality disorders.

Grilo CM, McGlashan TH, Morey LC, Gunderson JG, Skodol AE, Shea MT, Sanislow CA, Zanarini MC, Bender D, Oldham JM, Dyck I, Stout RL.

Acta Psychiatr Scand. 2001 Oct;104(4):264-72.

PMID:
11722301
17.
18.
19.

An open trial of valproate in borderline personality disorder.

Stein DJ, Simeon D, Frenkel M, Islam MN, Hollander E.

J Clin Psychiatry. 1995 Nov;56(11):506-10.

PMID:
7592502
20.

[Symptoms of DSM IV borderline personality disorder in a nonclinical population of adolescents: study of a series of 35 patients].

Chabrol H, Chouicha K, Montovany A, Callahan S.

Encephale. 2001 Mar-Apr;27(2):120-7. French.

PMID:
11407263
Items per page

Supplemental Content

Write to the Help Desk